Target Price | €27.26 |
Price | €25.32 |
Potential | 7.64% |
Number of Estimates | 20 |
20 Analysts have issued a price target Bayer 2026 . The average Bayer target price is €27.26. This is 7.64% higher than the current stock price. The highest price target is €36.00 42.18% , the lowest is €20.00 21.01% . | |
A rating was issued by 22 analysts: 7 Analysts recommend Bayer to buy, 15 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2026 of 7.64% . Most analysts recommend the Bayer stock at Hold. |
18 Analysts have issued a sales forecast Bayer 2025 . The average Bayer sales estimate is €46.1b . This is 1.00% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €46.9b 0.69% , the lowest is €45.0b 3.40% .
This results in the following potential growth metrics:
2024 | €46.6b | 2.16% |
---|---|---|
2025 | €46.1b | 1.06% |
2026 | €46.9b | 1.62% |
2027 | €48.0b | 2.33% |
2028 | €49.5b | 3.23% |
2029 | €50.7b | 2.36% |
18 Analysts have issued an Bayer EBITDA forecast 2025. The average Bayer EBITDA estimate is €9.2b . This is 15.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €9.6b 19.88% , the lowest is €8.1b 0.62% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €12.8b | 30.71% |
---|---|---|
2025 | €9.2b | 27.64% |
2026 | €9.7b | 5.02% |
2027 | €10.2b | 5.36% |
2028 | €10.4b | 2.03% |
2029 | €10.4b | 0.05% |
2024 | 27.42% | 29.18% |
---|---|---|
2025 | 20.05% | 26.88% |
2026 | 20.72% | 3.34% |
2027 | 21.34% | 2.99% |
2028 | 21.09% | 1.17% |
2029 | 20.59% | 2.37% |
10 Bayer Analysts have issued a net profit forecast 2025. The average Bayer net profit estimate is €1.5b . This is 145.59% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.0b 162.74% , the lowest is €341m 110.47% .
This results in the following potential growth metrics and future Net Margins:
2024 | €-2.6b | 13.23% |
---|---|---|
2025 | €1.5b | 158.11% |
2026 | €2.2b | 49.17% |
2027 | €2.7b | 21.04% |
2028 | €3.1b | 15.24% |
2029 | €2.9b | 7.04% |
2024 | -5.48% | 11.31% |
---|---|---|
2025 | 3.22% | 158.81% |
2026 | 4.72% | 46.58% |
2027 | 5.58% | 18.22% |
2028 | 6.23% | 11.65% |
2029 | 5.66% | 9.15% |
10 Analysts have issued a Bayer forecast for earnings per share. The average Bayer EPS is €1.51 . This is 145.62% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.08 162.84% , the lowest is €0.35 110.57% .
This results in the following potential growth metrics and future valuations:
2024 | €-2.60 | 13.04% |
---|---|---|
2025 | €1.51 | 158.08% |
2026 | €2.25 | 49.01% |
2027 | €2.73 | 21.33% |
2028 | €3.14 | 15.02% |
2029 | €2.92 | 7.01% |
Current | -7.65 | 14.13% |
---|---|---|
2025 | 16.77 | 319.23% |
2026 | 11.24 | 32.98% |
2027 | 9.29 | 17.35% |
2028 | 8.06 | 13.24% |
2029 | 8.67 | 7.57% |
Based on analysts' sales estimates for 2025, the Bayer stock is valued at an EV/Sales of 1.27 and an P/S ratio of 0.53 .
This results in the following potential growth metrics and future valuations:
Current | 1.26 | 8.70% |
---|---|---|
2025 | 1.27 | 0.72% |
2026 | 1.25 | 1.59% |
2027 | 1.22 | 2.28% |
2028 | 1.18 | 3.12% |
2029 | 1.16 | 2.31% |
Current | 0.53 | 10.79% |
---|---|---|
2025 | 0.53 | 1.03% |
2026 | 0.52 | 1.60% |
2027 | 0.51 | 2.27% |
2028 | 0.50 | 3.13% |
2029 | 0.48 | 2.30% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Hold
➜
Hold
|
Unchanged | Apr 06 2025 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Mar 31 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
HSBC |
Hold
➜
Hold
|
Unchanged | Mar 23 2025 |
MWB RESEARCH AG |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Hold
➜
Hold
|
Apr 06 2025 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Mar 31 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 26 2025 |
Unchanged
HSBC:
Hold
➜
Hold
|
Mar 23 2025 |
Unchanged
MWB RESEARCH AG:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.